Acamprosate and naltrexone have 5% to 8% success rates over 12 weeks

JAMA just published a meta analysis of medications used to treat alcoholism. Here are their findings: To prevent 1 person from returning to any drinking, the NNTs were 12 (95% CI, 8 to 26; 16 trials, n = 4847) and 20 (95% CI, 11 to 500; 16 trials, n = 2347) for acamprosate and oral naltrexone (50 mg/d), respectively. … Continue reading Acamprosate and naltrexone have 5% to 8% success rates over 12 weeks